Cytophage Technologies Ltd. (TSXV:CYTO)
0.0650
0.00 (0.00%)
Apr 27, 2026, 1:38 PM EST
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 4.40 million as of April 29, 2026. Its market cap has decreased by -68.01% in one year.
Market Cap
4.40M
Enterprise Value
5.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has decreased from 5.25M to 4.40M, a decrease of -16.20%. That is a compound annual growth rate of -4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 4.40M | -56.67% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Doseology Sciences | 4.97M |
| Restart Life Sciences | 5.05M |
| MYND Life Sciences | 5.22M |
| ASEP Medical Holdings | 3.45M |
| Quest PharmaTech | 5.92M |
| Aptose Biosciences | 6.00M |
| Kane Biotech | 6.36M |
| MindBio Therapeutics | 6.99M |